Although the dosages of PhIP and 6-shogaol in the in vitro experiments are not perfectly relevant to human exposure, this study is still the first to demonstrate that PTHrP produced by PhIP-exposed human 786-O renal cell carcinoma cells contributed to bone metastasis by increasing osteoclastogenesis. Here, PTHLH is linked to renal cell carcinoma.